HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regioselective conjugation of chitosan with a laminin-related peptide, Tyr-Ile-Gly-Ser-Arg, and evaluation of its inhibitory effect on experimental cancer metastasis.

Abstract
A conjugate from the YIGSR peptide and chitosan has been prepared on the basis of a regioselective modification strategy of chitosan, and its antimetastatic activity has been assayed. Chitosan was converted to its organosoluble derivative, 6-O-trityl-chitosan, in 3 steps, and then coupled with the peptide portion containing a spacer amino acid, Ac-Tyr-Ile-Gly-Ser-Arg-beta Ala-OH [beta Ala; beta-alanine]. The product was treated with CHCl2CO2H to afford the desired conjugate, Ac-Tyr-Ile-Gly-Ser-Arg-beta Ala-chitosan, which proved to inhibit the experimental lung metastasis of B16BL6 melanoma cells in mice at lower doses than the parent peptide.
AuthorsY Nishiyama, T Yoshikawa, K Kurita, K Hojo, H Kamada, Y Tsutsumi, T Mayumi, K Kawasaki
JournalChemical & pharmaceutical bulletin (Chem Pharm Bull (Tokyo)) Vol. 47 Issue 3 Pg. 451-3 (Mar 1999) ISSN: 0009-2363 [Print] Japan
PMID10212395 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Laminin
  • Oligopeptides
  • tyrosyl-isoleucyl-glycyl-seryl-arginine
  • Chitin
  • Chitosan
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Chitin (analogs & derivatives, chemistry)
  • Chitosan
  • Laminin (chemistry)
  • Lung Neoplasms (drug therapy, secondary)
  • Melanoma, Experimental (pathology)
  • Mice
  • Oligopeptides (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: